Latest Schedule 13G passive stakes
NASDAQ
CLFD
Clearfield, INCAIGH Capital Management and affiliated entities report beneficial ownership of 1,008,469 shares, representing 7.4% of Clearfield, Inc.'s common stock.
NASDAQ
NNBR
Nn INCOrin Hirschman and affiliated entities report a 9.7% stake in NN, Inc. common stock as of June 30, 2026.
NASDAQ
VUZI
Vuzix CORPAIGH Capital Management and affiliated entities report beneficial ownership of 8.1% of Vuzix Corporation's common stock as of June 30, 2026.
NASDAQ
DOMO
Domo, INCAIGH Capital Management and affiliated entities report a 6.9% beneficial ownership of Domo, Inc.'s Class B Common Stock.
NASDAQ
AIGH Capital Management and affiliated entities now beneficially own 9.1% of Spruce Biosciences' common stock, as disclosed in a Schedule 13G filing.
NASDAQ
ONCO
Onconetix, INCKeystone Capital Partners, RANZ Group, and Fredric Zaino have jointly filed a Schedule 13G, reporting beneficial ownership of 223,717 shares of Onconetix, Inc. common stock, representing 6.1% of the outstanding shares.
NYSE
Horizon Kinetics Asset Management LLC and its parent Horizon Kinetics Holding Corp. have reported beneficial ownership of 6.9% of EagleRock Land, LLC's Class A shares.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 38,598,106 shares, representing 7.4% of 3M Company's common stock as of June 30, 2026.
NYSE
MMM
3m COJPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 38,598,106 shares, representing 7.4% of 3M Company's common stock as of June 30, 2026.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 7.6% of Warner Music Group Corp.'s Class A Common Stock as of June 30, 2026.
NASDAQ
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 7.6% of Warner Music Group Corp.'s Class A Common Stock as of June 30, 2026.
NYSE
SCHEDULE: JPMorgan Chase Discloses Ventas Stake
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 8.7% of Ventas, Inc. common stock as of June 30, 2026.
NYSE
VTR
Ventas, INCSCHEDULE: JPMorgan Chase Discloses Ventas Stake
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 8.7% of Ventas, Inc. common stock as of June 30, 2026.
NYSE
SCHEDULE: JPMorgan Chase Discloses Twilio Stake
JPMorgan Chase & Co. has reported a significant beneficial ownership stake of 8.0% in Twilio Inc.'s Class A Common Stock as of June 30, 2026.
NYSE
TWLO
Twilio INCSCHEDULE: JPMorgan Chase Discloses Twilio Stake
JPMorgan Chase & Co. has reported a significant beneficial ownership stake of 8.0% in Twilio Inc.'s Class A Common Stock as of June 30, 2026.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 5.6% of Trane Technologies PLC's ordinary shares as of June 30, 2026.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 5.6% of Trane Technologies PLC's ordinary shares as of June 30, 2026.
YHD
Feis Equities LLC and Lawrence M. Feis have jointly reported beneficial ownership of 863,002 ordinary shares, representing 7.5% of the class, in Southern Cross Acquisition I Corp.
NYSE
Feis Equities LLC and Lawrence M. Feis have filed a Schedule 13G, reporting beneficial ownership of 354,052 Class A Ordinary Shares of Plutonian Acquisition Corp. II, representing 3.29% of the class.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 6.6% of NXP Semiconductors N.V. common shares as of June 30, 2026.
NASDAQ
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 6.6% of NXP Semiconductors N.V. common shares as of June 30, 2026.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 6.3% of Neurocrine Biosciences, Inc. common stock as of June 30, 2026.
NASDAQ
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 6.3% of Neurocrine Biosciences, Inc. common stock as of June 30, 2026.
NYSE
JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting beneficial ownership of 7.0% of Lemonade, Inc. common stock as of June 30, 2026.
NYSE
LMND
Lemonade, INCJPMorgan Chase & Co. has filed an amended Schedule 13G, reporting beneficial ownership of 7.0% of Lemonade, Inc. common stock as of June 30, 2026.
NYSE
SCHEDULE: JPMorgan Chase Discloses Stake in FIS
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 5.2% of Fidelity National Information Services, Inc. common stock as of June 30, 2026.
NYSE
SCHEDULE: JPMorgan Chase Discloses Stake in FIS
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 5.2% of Fidelity National Information Services, Inc. common stock as of June 30, 2026.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 13.0% of DigitalOcean Holdings, Inc. common stock as of June 30, 2026.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 13.0% of DigitalOcean Holdings, Inc. common stock as of June 30, 2026.
NYSE
JPMorgan Chase & Co. has filed a Schedule 13G, reporting a beneficial ownership of 9.8% in Burlington Stores, Inc. common stock as of June 30, 2026.